48,830
edits
(+ partial list of WHO) |
(→WHO classification: finish) |
||
Line 162: | Line 162: | ||
**Undifferentiated carcinoma with osteoclast-like giant cells. | **Undifferentiated carcinoma with osteoclast-like giant cells. | ||
**Mixed ductal-endocrine carcinoma. | **Mixed ductal-endocrine carcinoma. | ||
*[[Pancreatic serous cystadenocarcinoma|Serous cystadenocarcinoma]]. | |||
*[[Pancreatic mucinous cystadenocarcinoma|Mucinous cystadenocarcinoma]]. | |||
**Invasive. | |||
**Noninvasive. | |||
*[[Intraductal papillary mucinous neoplasm|Intraductal papillary mucinous carcinoma]]. | |||
**Invasive. | |||
**Noninvasive. | |||
*[[Acinar cell carcinoma]]. | |||
*[[Pancreatoblastoma]]. | |||
*[[Solid pseudopapillary neoplasm|Solid pseudopapillary carcinoma]]. | |||
Soft tissue tumours: | |||
*See ''[[soft tissue lesions]]''. | |||
==Cystic lesions of the pancreas== | ==Cystic lesions of the pancreas== |
edits